Review





Similar Products

95
Chem Impex International bis dimethylamino methylene
Bis Dimethylamino Methylene, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o+n/O-(7-Azabenzotriazol-1-yl)-N%2CN%2CN'%2CN'-tetramethyluronium+hexafluorophosphate/pmc13746262-119-0-10
Average 95 stars, based on 1 article reviews
bis dimethylamino methylene - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Thermo Fisher o bis
O Bis, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o+n/N%2CO-Bis(trimethylsilyl)trifluoroacetamide%2C+with+1%25+TMCS%2C+packaged+under+Argon+in+resealable+ChemSeal+bottles/pm42332570-97-27-53
Average 94 stars, based on 1 article reviews
o bis - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Proteintech o linked n acetylglucosamine transferase ogt antibody
Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct <t>OGT-mediated</t> modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; <t>OGT,</t> <t>O-linked</t> <t>N-acetylglucosamine</t> <t>transferase;</t> O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.
O Linked N Acetylglucosamine Transferase Ogt Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o+n/OGT+Antibody/pmc13748456-116-1-11
Average 96 stars, based on 1 article reviews
o linked n acetylglucosamine transferase ogt antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
Chem Impex International coupling agent azabenzotriazole tetramethyluronium hexafluorophosphate hatu
Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct <t>OGT-mediated</t> modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; <t>OGT,</t> <t>O-linked</t> <t>N-acetylglucosamine</t> <t>transferase;</t> O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.
Coupling Agent Azabenzotriazole Tetramethyluronium Hexafluorophosphate Hatu, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o+n/O-(7-Azabenzotriazol-1-yl)-N%2CN%2CN'%2CN'-tetramethyluronium+hexafluorophosphate/pm42910622-347-22-38
Average 95 stars, based on 1 article reviews
coupling agent azabenzotriazole tetramethyluronium hexafluorophosphate hatu - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
MACHEREY NAGEL n o 29 bis
Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct <t>OGT-mediated</t> modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; <t>OGT,</t> <t>O-linked</t> <t>N-acetylglucosamine</t> <t>transferase;</t> O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.
N O 29 Bis, supplied by MACHEREY NAGEL, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o+n/Derivatization+reagents+for+GC%2C+silylation%2C+BSTFA/pm42874066-412-11-14
Average 93 stars, based on 1 article reviews
n o 29 bis - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Jena Bioscience 30 o
Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct <t>OGT-mediated</t> modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; <t>OGT,</t> <t>O-linked</t> <t>N-acetylglucosamine</t> <t>transferase;</t> O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.
30 O, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o+n/Mant-GDP/pm42757569-175-4-27
Average 95 stars, based on 1 article reviews
30 o - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

86
Oakwood Chemical phase peptide synthesis o benzotriazol 1 yl n
Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct <t>OGT-mediated</t> modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; <t>OGT,</t> <t>O-linked</t> <t>N-acetylglucosamine</t> <t>transferase;</t> O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.
Phase Peptide Synthesis O Benzotriazol 1 Yl N, supplied by Oakwood Chemical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o+n/1+1+1+1h+3+3tetramethyluronium+6+chemical+chlorobenzotriazole+hexafluorophosphate+o+oakwood+yl/pm42284158-259-7-25
Average 86 stars, based on 1 article reviews
phase peptide synthesis o benzotriazol 1 yl n - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Macklin Inc o benzotriazole n
Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct <t>OGT-mediated</t> modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; <t>OGT,</t> <t>O-linked</t> <t>N-acetylglucosamine</t> <t>transferase;</t> O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.
O Benzotriazole N, supplied by Macklin Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o+n/benzotriazole+hexafluoro+n+n+n+n+o+phosphate+tetramethyl+uronium/pm42276237-51-15-31
Average 86 stars, based on 1 article reviews
o benzotriazole n - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Stanmore Implants Worldwide Ltd r t i c l e i n f o keywords
Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct <t>OGT-mediated</t> modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; <t>OGT,</t> <t>O-linked</t> <t>N-acetylglucosamine</t> <t>transferase;</t> O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.
R T I C L E I N F O Keywords, supplied by Stanmore Implants Worldwide Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o+n/c+e+f+i+i+keywords+l+n+o+r+t/pm42284708-17-45-28
Average 86 stars, based on 1 article reviews
r t i c l e i n f o keywords - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Ameta International dce 110 ̊c o h n pph2 pph2 pd omsh2n nixantphos pd g3
Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct <t>OGT-mediated</t> modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; <t>OGT,</t> <t>O-linked</t> <t>N-acetylglucosamine</t> <t>transferase;</t> O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.
Dce 110 ̊c O H N Pph2 Pph2 Pd Omsh2n Nixantphos Pd G3, supplied by Ameta International, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/o+n/110+dce+g3+h+n+nixantphos+o+omsh2n+pd+pd+pph2+pph2+%CC%8Ac/pm42259818-99-20-0
Average 86 stars, based on 1 article reviews
dce 110 ̊c o h n pph2 pph2 pd omsh2n nixantphos pd g3 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct OGT-mediated modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; OGT, O-linked N-acetylglucosamine transferase; O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.

Journal: Frontiers in Cell and Developmental Biology

Article Title: A SERPINA1-associated SOX4–FN1 epithelial program linked to lymphatic endothelial responses in aggressive papillary thyroid carcinoma

doi: 10.3389/fcell.2026.1929991

Figure Lengend Snippet: Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct OGT-mediated modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; OGT, O-linked N-acetylglucosamine transferase; O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.

Article Snippet: The O-linked N-acetylglucosamine transferase (OGT) antibody was mouse monoclonal, clone 2B2A6 (Proteintech, 66823-1-Ig; reference western blot dilution, 1:10000).

Techniques: Functional Assay, Expressing, In Vitro, Biomarker Discovery, ChIP-qPCR, Knockdown, Migration, In Vivo, Modification, Proximity Ligation Assay, Co-Immunoprecipitation Assay, Single Cell, RNA Sequencing, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction